1. Home
  2. ARI vs AKBA Comparison

ARI vs AKBA Comparison

Compare ARI & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARI
  • AKBA
  • Stock Information
  • Founded
  • ARI 2009
  • AKBA 2007
  • Country
  • ARI United States
  • AKBA United States
  • Employees
  • ARI N/A
  • AKBA N/A
  • Industry
  • ARI Real Estate Investment Trusts
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARI Real Estate
  • AKBA Health Care
  • Exchange
  • ARI Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • ARI 1.1B
  • AKBA 958.6M
  • IPO Year
  • ARI 2009
  • AKBA 2014
  • Fundamental
  • Price
  • ARI $9.73
  • AKBA $3.85
  • Analyst Decision
  • ARI Hold
  • AKBA Strong Buy
  • Analyst Count
  • ARI 5
  • AKBA 5
  • Target Price
  • ARI $10.08
  • AKBA $6.90
  • AVG Volume (30 Days)
  • ARI 1.4M
  • AKBA 3.9M
  • Earning Date
  • ARI 07-29-2025
  • AKBA 08-07-2025
  • Dividend Yield
  • ARI 10.29%
  • AKBA N/A
  • EPS Growth
  • ARI N/A
  • AKBA N/A
  • EPS
  • ARI N/A
  • AKBA N/A
  • Revenue
  • ARI $276,844,000.00
  • AKBA $184,909,000.00
  • Revenue This Year
  • ARI $32.11
  • AKBA $26.88
  • Revenue Next Year
  • ARI $19.41
  • AKBA $44.34
  • P/E Ratio
  • ARI N/A
  • AKBA N/A
  • Revenue Growth
  • ARI 104.64
  • AKBA N/A
  • 52 Week Low
  • ARI $7.70
  • AKBA $1.07
  • 52 Week High
  • ARI $11.20
  • AKBA $4.08
  • Technical
  • Relative Strength Index (RSI)
  • ARI 44.67
  • AKBA 62.44
  • Support Level
  • ARI $9.80
  • AKBA $3.81
  • Resistance Level
  • ARI $10.04
  • AKBA $4.08
  • Average True Range (ATR)
  • ARI 0.17
  • AKBA 0.15
  • MACD
  • ARI -0.02
  • AKBA -0.02
  • Stochastic Oscillator
  • ARI 35.45
  • AKBA 68.45

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: